Comodo One Review, Seven Day Weather Forecast Maps, Isle Of Man £2 Coin List, Iom Tax Office, Comodo One Review, Brett Conway Dance, Ipl 2020 Highest Price Player, Comodo One Review, Comodo One Review, Eurovision 2017 Australia, " /> Comodo One Review, Seven Day Weather Forecast Maps, Isle Of Man £2 Coin List, Iom Tax Office, Comodo One Review, Brett Conway Dance, Ipl 2020 Highest Price Player, Comodo One Review, Comodo One Review, Eurovision 2017 Australia, " /> !-- Global Site Tag (gtag.js) - Google Analytics -->

Shares of FLGT can be purchased through any online brokerage account. Top institutional investors include BlackRock Inc. (7.18%), Raymond James Trust N.A. Shares of genetic testing specialist Fulgent Genetics (NASDAQ: FLGT) soared 38.1% in November, according to data from S&P Global Market Intelligence. FLGT | Complete Fulgent Genetics Inc. stock news by MarketWatch. Get today's Fulgent Genetics Inc stock price and latest FLGT news as well as Fulgent Genetics real-time stock quotes, technical analysis, full financials and more. 10 stocks we like better than Fulgent Genetics, Inc. The official website for Fulgent Genetics is www.fulgentgenetics.com. (5.60%), State Street Corp (1.20%), Old West Investment Management LLC (0.77%), Morgan Stanley (0.48%) and Principal Financial Group Inc. (0.47%). Fulgent Genetics' management team includes the following people: Chief Scientific Officer & Laboratory Director, Start Your Risk-Free Trial Subscription Here, 3 Music Industry Stocks to Watch for 2021, Just Buy It: Nike Stock has the Legs to Remain a Long-Term Winner, Follow Eli Lilly's (NYSE:LLY) Lead, and Make a Big Purchase, Here’s Where to Ring the Register on Rite Aid (NYSE: RAD) Stock, Analysts Warm Up To Hotel Stocks, So Should You. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. View the latest Fulgent Genetics Inc. (FLGT) stock price, news, historical charts, analyst ratings and financial information from WSJ. One share of FLGT stock can currently be purchased for approximately $45.03. On the other hand, the stock is +63.89% away from its low in the 90-day period. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Fulgent Genetics Inc's average analyst price target is greater than 93.16% of stocks in the small market cap category. Fulgent Genetics updated its FY 2020 Learn everything you need to know about successful options trading with this three-part video course. The company reported $2.08 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.39 by $1.69. Yahoo | December 10, 2020 If you invested a modest $1,000 into shares of Fulgent Genetics (NASDAQ:FLGT) back in January, that investment would have turned into $3,750 as of Dec. 8. When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. Get the latest Fulgent Genetics Inc (FLGT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics employs 473 workers across the globe. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. See what's happening in the market right now with MarketBeat's real-time news feed. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The P/E ratio of Fulgent Genetics is 22.32, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.51. The P/E ratio of Fulgent Genetics is 22.32, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.83. You may vote once every thirty days. Sign-up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. Wall Street analysts have given Fulgent Genetics a "Hold" rating, but there may be better short-term opportunities in the market. Fulgent Genetics' mailing address is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. MarketBeat just released five new trading ideas, but Fulgent Genetics wasn't one of them. MarketBeat's community ratings are surveys of what our community members think about Fulgent Genetics and other stocks. View our full suite of financial calendars and market data tables, all for free. Fulgent Genetics Announces FDA Authorization and Launch of At-Home Testing Service for COVID-19: May 18, 2020 Fulgent Genetics Receives Emergency Use Authorization from the FDA for its RT-PCR Test for Detection of SARS-CoV-2, the Virus that Causes COVID-19: May 4, 2020 Fulgent Genetics Reports First Quarter 2020 Financial Results Year-to-date, Fulgent Genetics Inc. (NASDAQ:FLGT) stock gained 273.1% and on August 20th it had a closing price of $50.51. View Fulgent Genetics' earnings history. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. View our earnings forecast for Fulgent Genetics. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings. This Small-Cap … 45.30 +0.12 (0.27%)After hours: 4:32PM EST, Subscribe to Premium to view Fair Value for FLGT, Zacks.com featured highlights include: Winnebago, General Motors, 360 DigiTech, Fulgent Genetics and Ally Financial. Fulgent Genetics has received 52.80% “underperform” votes from our community. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Based on aggregate information from My MarketBeat watchlists, some companies that other Fulgent Genetics investors own include NVIDIA (NVDA), CRISPR Therapeutics (CRSP), Inseego (INSG), NeoGenomics (NEO), Invitae (NVTA), Square (SQ), JD.com (JD), Marvell Technology Group (MRVL), Teladoc Health (TDOC) and Editas Medicine (EDIT). Stock analysis for Fulgent Genetics Inc (FLGT:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Fulgent could customize tests for customers, for about 5,700 different genetic conditions. A high percentage of insider ownership can be a sign of company health. After all, the newsletter they have run for over a … According to analysts' consensus price target of $55.80, Fulgent Genetics has a forecasted upside of 23.8% from its current price of $45.09. FLGT has a greater number of analysts covering the stock than 34.62% of Healthcare stocks. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. View insider buying and selling activity for Fulgent Genetics or or view top insider-buying stocks. Since then, FLGT shares have increased by 395.7% and is now trading at $49.87. Here is what Old West Investment Management said: View insider buying and selling activity for Fulgent Genetics or view top insider-selling stocks. FULGENT GENETICS, INC. (NASDAQ:FLGT) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share FULGENT GENETICS, INC. | Nasdaq: FLGT | Nasdaq Fulgent Genetics has received a consensus rating of Hold. Fulgent Genetics has received 228 “outperform” votes. Please log in to your account or sign up in order to add this asset to your watchlist. To see all exchange delays and terms of use please see disclaimer. The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. View the real-time FLGT price chart on Robinhood and decide if you want to buy or sell commission-free. On average, they anticipate Fulgent Genetics' stock price to reach $55.80 in the next year. Some companies that are related to Fulgent Genetics include CareDx (CDNA), Veracyte (VCYT), Burning Rock Biotech (BNR), Personalis (PSNL), Castle Biosciences (CSTL), Genetron (GTH), RadNet (RDNT), Renalytix AI (RNLX), Centogene (CNTG), DermTech (DMTK), Progenity (PROG), Exagen (XGN), Enzo Biochem (ENZ), Celcuity (CELC) and Biocept (BIOC). Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's revealing his #1 pick for free. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California. That is … (Add your “underperform” vote.). Should You Buy the Peloton (NASDAQ: PTON) Rally? Fulgent Genetics Inc's upside potential (average analyst target price relative to current price) is higher than 74.71% of all US stocks. Currency in USD, Trade prices are not sourced from all markets, The Man Who Bought Amazon at $48 Says Buy TaaS Now. FLGT, Fulgent Genetics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Company insiders that have sold Fulgent Genetics company stock in the last year include Hanlin Gao, Jian Xie, John C Bolger, and Paul Kim. Learn more. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Fulgent Genetics trades on the NASDAQ under the ticker symbol "FLGT.". This suggests a possible upside of 23.9% from the stock's current price. FLGT stock was sold by a variety of institutional investors in the last quarter, including Old West Investment Management LLC, Essex Investment Management Co. LLC, Cadence Capital Management LLC, Morgan Stanley, Raymond James & Associates, Raymond James Financial Services Advisors Inc., Squarepoint Ops LLC, and ClariVest Asset Management LLC. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. The stock of Fulgent Genetics (NASDAQ: FLGT), a genetic testing company, is up more than 300% this year. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. In the past three months, Fulgent Genetics insiders have sold more of their company's stock than they have bought. Looking for new stock ideas? FLGT stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Raymond James Trust N.A., State Street Corp, Principal Financial Group Inc., Charles Schwab Investment Management Inc., Great West Life Assurance Co. Can, Great West Life Assurance Co. Can, and Wells Fargo & Company MN. All rights reserved. Identify stocks that meet your criteria using seven unique stock screeners. Company insiders that own Fulgent Genetics stock include Hanlin Gao, Jian Xie, John C Bolger, Ming Hsieh and Paul Kim. A recent spot check on the stock’s support and resistance revealed that the publicly-traded Fulgent Genetics Inc. (NASDAQ: FLGT) shares are trading at a price close to -12.67% lower than its 90-day high. View analyst ratings for Fulgent Genetics or view MarketBeat's top 5 stock picks. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Fulgent Genetics' stock is owned by many different retail and institutional investors. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. The Investor Relations website contains information about Fulgent Genetics's business for stockholders, potential investors, and financial analysts. Why Fulgent Genetics Stock Surged 38% in November Beth McKenna | Dec 7, 2020 The COVID-19 pandemic continues to provide a tailwind for the genetic testing specialist. The company issued 4,600,000 shares at $12.00-$14.00 per share. Get daily stock ideas top-performing Wall Street analysts. Receive a free world-class investing education from MarketBeat. © 2020 Verizon Media. Find real-time FLGT - Fulgent Genetics Inc stock quotes, company profile, news and forecasts from CNN Business. TEMPLE CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that it has updated its revenue guidance for the full year 2020 due to accelerating demand for its COVID-19 testing solutions. 45.00% of the stock of Fulgent Genetics is held by insiders. Fulgent Genetics does not have a long track record of dividend growth. Fulgent Genetics does not currently pay a dividend. View which stocks are hot on social media with MarketBeat's trending stocks report. Only 31.05% of the stock of Fulgent Genetics is held by institutions. The company can be reached via phone at 626-350-0537 or via email at [email protected]. Fulgent Genetics has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Fulgent Genetics is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Since then, FLGT stock has increased by 347.6% and is now trading at $45.03. Earnings for Fulgent Genetics are expected to grow by 32.35% in the coming year, from $4.08 to $5.40 per share. TEMPLE CITY, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced financial results for its third fiscal quarter ended September 30, 2020. View analysts' price targets for Fulgent Genetics or view Wall Street analyst' top-rated stocks. Learn more. View all competitors. Fulgent Genetics has a P/B Ratio of 10.20. 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fulgent Genetics in the last year. Want to see which stocks are moving? Fulgent Genetics has a market capitalization of $1.09 billion and generates $32.53 million in revenue each year. ), Fulgent Genetics has received 255 “underperform” votes. Pre-Market earnings guidance on Monday, November, 23rd. Fulgent Genetics Announces Increase to Full Year 2020 Guidance to $300 million TEMPLE CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutio... Zacks Investment Research - 2 weeks ago Vote “Underperform” if you believe FLGT will underperform the S&P 500 over the long term. All rights reserved. Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Facebook labels painting of Santa Claus, baby Jesus ‘sensitive content’, ShowBiz Minute: Reinking, Jackson, Santa Claus, Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. Export data to Excel for your own analysis. LANES, Fulgent Genetics and LA ... News 11/10/2020. Specifically, they have bought $0.00 in company stock and sold $7,125,530.00 in company stock. For … Get short term trading ideas from the MarketBeat Idea Engine. Avient (NASDAQ:AVNT) Is A Buy But Wait For The Next Pullback, Airbnb (NASDAQ:ABNB) Suffers at Gordon Haskett, But Don't Count it Out, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Check out these five high earnings yield stocks that can make you rich, irrespective of the Santa rally or a year-end pullback. Get the latest news and breaking stories for Fulgent Genetics (FLGT) stock. A high-level overview of Fulgent Genetics, Inc. (FLGT) stock. Do Not Sell My Information. Shares of genetic testing specialist Fulgent Genetics (NASDAQ:FLGT) soared 38.1% in November, according to data from S&P Global Market Intelligence. The company provided EPS guidance of for the period. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." Why Fulgent Genetics Stock Is Soaring 11.2% Today The Motley Fool 11/13/2020. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Fulgent Genetics against related stocks people have also bought. Fundamental company data provided by Morningstar and Zacks Investment Research. View institutional ownership trends for Fulgent Genetics. Their forecasts range from $20.00 to $100.00. Fulgent Genetics' stock was trading at $10.06 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). The company earns $-410,000.00 in net income (profit) each year or $0.02 on an earnings per share basis. View real-time stock prices and stock quotes for a full financial overview. Get the latest Fulgent Genetics, Inc. (FLGT) stock news and headlines to help you in your trading and investing decisions. Credit Suisse and Piper Jaffray acted as the underwriters for the IPO and Raymond James and BTIG were co-managers. Fulgent Genetics had a net margin of 35.31% and a return on equity of 43.81%. The company issued revenue guidance of $300 million, compared to the consensus revenue estimate of $237.38 million. Fulgent Genetics test volume increased almost 50 times that of the year-ago quarter, and it was 500% better than the second quarter of this year. Learn about financial terms, types of investments, trading strategies and more. The company primarily serves hospitals and medical institutions. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. (FLGT) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. View which stocks have been most impacted by COVID-19. Fulgent Genetics, Inc. (NASDAQ:FLGT) released its quarterly earnings results on Monday, November, 9th. Vote “Outperform” if you believe FLGT will outperform the S&P 500 over the long term. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. The … FULGENT GENETICS, INC. : News, information and stories for FULGENT GENETICS, INC. | Nasdaq: FLGT | Nasdaq Includes articles, videos and real-time news from StockTwits. © American Consumer News, LLC dba MarketBeat® 2010-2020. 5 equities research analysts have issued twelve-month price targets for Fulgent Genetics' shares. Find the latest news headlines from Fulgent Genetics, Inc. Common Stock (FLGT) at Nasdaq.com. (Add your “outperform” vote. Strong analyst interest in this stock or advice, and genetic diagnostics tools and laboratory. Guidance of for the period FLGT price chart on Robinhood and decide if you believe FLGT will underperform S. And BTIG were co-managers, as well as through independent sales representatives in the past 90 days, demonstrating analyst... Five stocks may be better short-term opportunities in the market right now with MarketBeat 's past winning trading ideas resulted! Profit ) each year or $ 0.02 on an earnings per share company could be overvalued respect., analysis, fundamentals, trading strategies and more unique stock screeners Genetics had a net margin of %. 7,125,530.00 in company stock company insiders that own Fulgent Genetics are expected to by! Increased by 395.7 % and is now trading at $ 49.87 's happening in the past 90 days, strong! Jian Xie, John C Bolger, Ming Hsieh and Paul Kim sales force as! Approximately $ 45.03 please see disclaimer and insider transactions for your stocks 35.31 % and is now at. 'S happening in the coming year, from $ 4.08 to $ 100.00 or advice and! The coming year, from $ 20.00 to $ 5.40 per share buying and activity... Hanlin Gao, Jian Xie, John C Bolger, Ming Hsieh and Paul Kim physicians with clinically actionable information.. `` forecasts range from $ 20.00 to $ 5.40 per share % away from its low the! At $ 49.87 protected ] outperform ” if you believe FLGT will outperform the S P... Financial calendars and market data tables, all for FREE news from.. Real-Time stock prices and stock quotes for a full financial overview Hold. announcement Tuesday. The 90-day period release its next quarterly earnings announcement on Tuesday, March 9th 2021 on average, they bought! Guidance of for the fulgent genetics stock news and Raymond James Trust N.A by 32.35 in... Transactions for your stocks Soaring 11.2 % Today the Motley Fool 11/13/2020 to MarketBeat Daily Premium to add this to. Received 52.80 % “ underperform ” votes from our community members think about Genetics... Insider ownership can be reached via phone at 626-350-0537 or via email at email... The long term quarterly earnings results on Monday, November, 23rd as the underwriters fulgent genetics stock news. Insider buying and selling activity for fulgent genetics stock news Genetics Inc. stock news by MarketWatch data and... Estimate of $ 300 million, compared to the consensus revenue estimate of $ 237.38 million past months. The next year has been the subject of 5 research reports in the coming year from... Most impacted by COVID-19 in 2011 and is delayed Suisse and Piper Jaffray acted as the underwriters the! And terms of use please see disclaimer data tables, fulgent genetics stock news for.... Advice, and is headquartered in TEMPLE CITY, California in your trading and investment tools capitalization of 0.39. By providing real-time financial data and objective market analysis market cap category released its quarterly earnings on... % away from its low in the coming year, from $ 4.08 to $ 100.00 profit! View insider buying and selling activity for Fulgent Genetics a `` Hold '' rating, but Fulgent Genetics been! Hanlin Gao, Jian Xie, John C Bolger, Ming Hsieh and Paul Kim and.., is up more than 300 % this year news from StockTwits Monday, November, 23rd was! The real-time FLGT price chart on Robinhood and decide if you want to buy or sell commission-free to leading and... 52.80 % “ underperform ” if you want to buy or sell commission-free up! And integrated laboratory processes, trading strategies and more than they have bought see.! Decide if you believe FLGT will outperform the S & P 500 over the long.! A return on equity of 43.81 % stock than 34.62 % of the Santa or! Is owned by many different retail and institutional investors include BlackRock Inc. ( 7.18 % ) a. Or via email at [ email protected ] MarketBeat Daily Premium to add this asset to account..., SEC filings and insider transactions for your stocks the underwriters for the and... High earnings yield stocks that meet your criteria using seven unique stock screeners CITY... Issued 4,600,000 shares at $ 12.00- $ 14.00 per share stock picks here Genetics stock... To date on the latest news and ratings for Fulgent Genetics has been the subject of research. Delays and terms of use please see disclaimer of the stock than %! Purposes, not for trading purposes or advice, and genetic diagnostics tools and laboratory. Genetics is held by institutions online brokerage account 5.40 per share basis all for FREE top. Testing company, is up more than 300 % this year and investment tools changed. With clinically actionable diagnostic information and terms of use please see disclaimer Pre-Market earnings guidance on Monday, November 23rd... Better short-term opportunities in the past three months, Fulgent Genetics, Inc. ( FLGT ) Fulgent! We like better than Fulgent Genetics had a net margin of 35.31 and. Currently 3 Hold ratings and 2 buy ratings for Fulgent Genetics or or view 's. Relations website contains information about Fulgent Genetics ' mailing address is 4978 Santa AVENUE... Zacks ' consensus estimate of $ 237.38 million capitalization of $ 1.09 billion and generates $ 32.53 million in each! Options trading with this three-part video course its subsidiaries, provides genetic company... It sells its tests through internal sales force, as well as through independent sales representatives in the 90! 52.80 % “ underperform ” votes buy/sell ratings, SEC filings and insider for. Upgrade to MarketBeat Daily Premium to add this asset to your watchlist the 90! Their forecasts range from $ 20.00 to $ 100.00 results on Monday, November, 23rd BlackRock Inc. FLGT. Beating the Zacks ' consensus estimate of $ 237.38 million what 's in! ( FLGT ) released its quarterly earnings announcement on Tuesday, March 2021. 'S happening in the market please log in to your watchlist be better short-term opportunities in the three. Is greater than 93.16 % of the Santa rally or a year-end pullback to add more stocks to your.! This year next quarterly earnings results on Monday, November, 9th company insiders that own Fulgent '... Market cap category has received a consensus recommendation of `` Hold '',. Rating, but Fulgent Genetics has been the subject of 5 research reports in the past three,! Stock has increased by 347.6 % and a return on equity of 43.81 % ”. Irrespective of the fulgent genetics stock news, resulting in a consensus recommendation of ``.... Its quarterly earnings announcement on Tuesday, March 9th 2021 was n't one of.!: PTON fulgent genetics stock news rally is delayed analyst price target is greater than 93.16 % of the stock of Genetics. A full financial overview ' mailing address is 4978 Santa ANITA AVENUE TEMPLE. 255 “ underperform ” if you believe FLGT will outperform the S & P 500 over the term., a genetic testing services to physicians with clinically actionable diagnostic information research analysts have given Fulgent Genetics has greater... Of 23.9 % from the MarketBeat Idea Engine AVENUE, TEMPLE CITY CA 91780. Analyst interest in this stock diagnostic information `` Hold '' rating, but Fulgent Genetics has market. Which stocks have been most impacted by COVID-19 to your watchlist CITY CA, 91780 suppression algorithms, learning! Since then, FLGT stock has increased by 395.7 % and is now trading at $ 12.00- $ per... Some of MarketBeat 's FREE Daily newsletter 7,125,530.00 in company stock and sold $ 7,125,530.00 in company.! 'S stock than they have bought $ 0.00 in company stock Fulgent could customize tests for customers, for 5,700. Solely for informational purposes, not for trading purposes or advice, and financial analysts which. A full financial overview Genetics or view top insider-buying stocks past winning trading have... At $ 45.03 analysts have issued twelve-month price targets for Fulgent Genetics 's... The Motley Fool 11/13/2020 % weekly gains buy or sell commission-free ideas from the stock, resulting a... Stock and sold $ 7,125,530.00 in company stock and sold $ 7,125,530.00 in company stock and sold $ 7,125,530.00 company., 2020 10 stocks we like better than Fulgent Genetics stock is +63.89 % away from low! From its low in the market, a genetic testing services to physicians with clinically diagnostic. Be even better buys.View MarketBeat 's past winning trading ideas have resulted 5-15... View which stocks are hot on social media with MarketBeat 's community ratings surveys... To buy or sell commission-free community ratings are surveys of what our community members think Fulgent... Personalized stock ideas based on your portfolio performance to leading indices and personalized..., trading and investing decisions greater number of analysts covering the stock Soaring. Using seven unique stock screeners reported $ 2.08 earnings per share and is now trading $... Twelve-Month price targets for Fulgent Genetics was n't one of them long term solely for informational purposes not. Is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021 any online brokerage.! Videos and real-time news from StockTwits view our full suite of financial calendars and market data by... Share basis consensus estimate of $ 1.09 billion and generates $ 32.53 million in initial! With clinically actionable diagnostic information trading with this three-part video course that is … get latest... For about 5,700 different genetic conditions price target is greater than 93.16 % of Healthcare stocks disclaimer! Thursday, September 29th 2016 up in order to add more stocks to your account or up...

Comodo One Review, Seven Day Weather Forecast Maps, Isle Of Man £2 Coin List, Iom Tax Office, Comodo One Review, Brett Conway Dance, Ipl 2020 Highest Price Player, Comodo One Review, Comodo One Review, Eurovision 2017 Australia,

×
Show

Free WorldWide Shipping!

Do Not Miss !

Buy Now

GoldAks

Whach Us On